Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.50 |
| ▸ | FDPS | P14324 | 3/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14384380 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL13819794 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL8513608 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL13819798 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL13538692 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL13819793 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL574092 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL7912103 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL11386622 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 | |
| SCHEMBL12154896 | 1.00 | CA1 (0.61) | CA1ACE2GPR84FDPSFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680020-A1 | COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES | FMC Agricultural Solutions A/S (DK) | 2026-01-21 | — | — | EP | claimed |
| WO-2024189207-A1 | COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES | FMC Agricultural Solutions A/S (DK) | 2024-09-19 | — | — | WO | claimed |
| EP-0924183-B1 | Process for the production of dimethyldecanedioic acid | KURARAY CO (JP) | 2003-09-24 | — | — | EP | claimed |
| EP-4680020-A1 | COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES | FMC Agricultural Solutions A/S (DK) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024189207-A1 | COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES | FMC Agricultural Solutions A/S (DK) | 2024-09-19 | — | — | WO | disclosed |
| CN-115151534-B | Inhibitors of interleukin-1 receptor associated kinase (IRAK)/FMS-like receptor tyrosine kinase (FLT 3), pharmaceutical products thereof and methods of use thereof | 南京药石科技股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-115151534-A | Inhibitors of interleukin-1 receptor-related kinase (IRAK)/FMS-like receptor tyrosine kinase (FLT 3), pharmaceutical products thereof, and methods thereof | 南京药石科技股份有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-114450271-A | Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition | 纽力克斯治疗公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-109790284-B | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2021-09-21 | — | — | CN | disclosed |
| CN-105766907-B | A kind of Atrijuglans hetaohei sex pheromone component | 西北农林科技大学 | 2019-05-28 | — | — | CN | disclosed |
| US-8900791-B2 | Actinic ray-sensitive or radiation-sensitive resin composition and method of forming pattern with the composition | FUJIFILM CORPORATION (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8900791-B2 | Actinic ray-sensitive or radiation-sensitive resin composition and method of forming pattern with the composition | FUJIFILM CORPORATION (JP) | 2014-12-02 | — | — | US | disclosed |
| EP-2384111-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-20110171577-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110171577-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-07-14 | — | — | US | disclosed |
| WO-2010076316-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2010-07-08 | — | — | WO | disclosed |
| EP-0284363-A1 | 2, 6-dimethyl octylformate and an attractant of tribolium castaneum herbst | Japan Tobacco Inc. (JP) | 1988-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171577-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION | ARSA, RAD51, ARID2 | CA1 2459/4885ACE2 3779/4885GPR84 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.